Antiviral Agents

Overview

Journal Med Clin North Am

Specialty General Medicine

Date 1988 May 1

PMID 3280914

Citations 8

Authors

E D Reines

P A Gross

Affiliations

Soon will be listed here.

Abstract

Potent effective antiviral drugs recently have been licensed for several viral diseases, ushering in a new era in the treatment of viral diseases. Several unique features in the process of a viral infection have been identified as target points for inhibition. The unique steps and the interfering compounds are the subject of this review.

Citing Articles

Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety.

Herrine S, Brown Jr R, Bernstein D, Ondovik M, Lentz E, Te H Dig Dis Sci. 2005; 50(4):719-26.

PMID: 15844708 DOI: 10.1007/s10620-005-2563-3.

A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantadine versus interferon-alpha alone in the treatment of patients with chronic hepatitis C.

Ahmad J, Vargas H, Balan V, Rakela J, Shakil A Dig Dis Sci. 2002; 47(7):1655-6.

PMID: 12141832 DOI: 10.1023/a:1015804227191.

Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis.

Weiss R, Cox N, Martinez M Res Vet Sci. 1993; 55(2):162-72.

PMID: 8235082 PMC: 7131103. DOI: 10.1016/0034-5288(93)90076-r.

Toxicologic effects of ribavirin in cats.

Weiss R, Cox N, Boudreaux M J Vet Pharmacol Ther. 1993; 16(3):301-16.

PMID: 8230401 PMC: 7167023. DOI: 10.1111/j.1365-2885.1993.tb00177.x.

Adverse effects and drug interactions of clinical importance with antiviral drugs.

Morris D Drug Saf. 1994; 10(4):281-91.

PMID: 8018300 DOI: 10.2165/00002018-199410040-00002.

References

Balzarini J, Mitsuya H, De Clercq E, Broder S . Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). Int J Cancer. 1986; 37(3):451-7. DOI: 10.1002/ijc.2910370318. View

. Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting. Bull World Health Organ. 1985; 63(1):51-6. PMC: 2536349. View

McClung H, Knight V, Gilbert B, Wilson S, Quarles J, Divine G . Ribavirin aerosol treatment of influenza B virus infection. JAMA. 1983; 249(19):2671-4. View

Toltzis P, Huang A . Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells. Antimicrob Agents Chemother. 1986; 29(6):1010-6. PMC: 180493. DOI: 10.1128/AAC.29.6.1010. View

Reichman R, Badger G, Mertz G, Corey L, Richman D, Connor J . Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA. 1984; 251(16):2103-7. View

Couch R, KASEL J, Glezen W, CATE T, Six H, Taber L . Influenza: its control in persons and populations. J Infect Dis. 1986; 153(3):431-40. DOI: 10.1093/infdis/153.3.431. View

Felsenstein D, DAmico D, Hirsch M, Neumeyer D, Cederberg D, de Miranda P . Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Ann Intern Med. 1985; 103(3):377-80. DOI: 10.7326/0003-4819-103-3-377. View

Cole N, Balfour Jr H . Varicella-Zoster virus does not become more resistant to acyclovir during therapy. J Infect Dis. 1986; 153(3):605-8. DOI: 10.1093/infdis/153.3.605. View

Krasny H, Liao S, de Miranda P, Laskin O, WHELTON A, Lietman P . Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure. Am J Med. 1982; 73(1A):202-4. DOI: 10.1016/0002-9343(82)90091-2. View

10.

Hayden F, Albrecht J, Kaiser D, Gwaltney Jr J . Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med. 1986; 314(2):71-5. DOI: 10.1056/NEJM198601093140202. View

11.

Whitley R, Soong S, Dolin R, Galasso G, Chien L, Alford C . Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977; 297(6):289-94. DOI: 10.1056/NEJM197708112970601. View

12.

. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep. 1986; 35(20):317-26, 331. View

13.

Lagrew Jr D, Furlow T, Hager W, Yarrish R . Disseminated herpes simplex virus infection in pregnancy. Successful treatment with acyclovir. JAMA. 1984; 252(15):2058-9. View

14.

Scullard G, Andres L, Greenberg H, Smith J, Sawhney V, Neal E . Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Hepatology. 1981; 1(3):228-32. DOI: 10.1002/hep.1840010306. View

15.

Mertz G, Critchlow C, Benedetti J, Reichman R, Dolin R, Connor J . Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA. 1984; 252(9):1147-51. View

16.

Corey L, Fife K, Benedetti J, WINTER C, Fahnlander A, Connor J . Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med. 1983; 98(6):914-21. DOI: 10.7326/0003-4819-98-6-914. View

17.

Gold D, Corey L . Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother. 1987; 31(3):361-7. PMC: 174733. DOI: 10.1128/AAC.31.3.361. View

18.

Bean B, Aeppli D . Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis. 1985; 151(2):362-5. DOI: 10.1093/infdis/151.2.362. View

19.

Aronoff G, Szwed J, Nelson R, Marcus E, Kleit S . Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration to a patient with renal failure. Antimicrob Agents Chemother. 1980; 18(1):212-4. PMC: 283968. DOI: 10.1128/AAC.18.1.212. View

20.

Keller P, Fyfe J, Beauchamp L, Lubbers C, Furman P, Schaeffer H . Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem Pharmacol. 1981; 30(22):3071-7. DOI: 10.1016/0006-2952(81)90495-0. View